H-Phg-OtBu
53934-78-4
|
DL-Phg-Otbu
124619-74-5
|
(R)-Phenylglycine tert-butyl ester hydrochloride
256478-95-2
|
DAPT (GSI-IX)
208255-80-5
|
Fms-Val-OtBu
1245735-69-6
|
Fms-Pro-OtBu
1245735-71-0
|
Fms-Gly-OtBu
1245735-65-2
|
Z-Phg-Phe-OtBu
111524-82-4
|
L-Glutamic acid,N-[4-[2-(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)ethyl]benzoyl]- (9CI)
33963-89-2
|
2-(3-methoxyphenyl)-4-methyl-N-[(2E)-5-(2-methylpropyl)-1,3,4-thiadiazol-2(3H)-ylidene]-1,3-thiazole-5-carboxamide
1232826-68-4
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
